Description
The U.S. Food and Drug Administration (FDA) is seeking a Microarray System with Analysis Package to measure the potency of the neuraminidase component in influenza vaccines. The system should be able to analyze all subtypes of HA or NA in multiplexed vaccine products in a single test, provide results within one workday, and have a sensitivity of at or below 1 microgram/mL. The system should also include racks and containers for storing and washing slides, assay kits, and software for automated data analysis.
• The system must be compatible with Windows 10
• The system must include a warranty of at least one year from the date of instrument acceptance
• The system must include installation of the equipment and software
• The system must include onsite qualification and training
The FDA is looking for a firm-fixed-price contract, and the award will be made to the lowest priced, technically acceptable, and responsible offeror.